Epitope spreading: The role of self peptides and autoantigen processing by B lymphocytes

Immunological Reviews

Volumn 164, Issue , 1998, Pages 231-233

  Mamula, Mark J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; EPITOPE;

ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BACTERIAL IMMUNITY; IMMUNE RESPONSE; MACROMOLECULE; PRIORITY JOURNAL; VIRUS IMMUNITY;

EID: 0031784721     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01223.x     Document Type: Article

References (57)

1. Van der Most RG, et al. Analysis of cytotoxic T-cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J Immunol 1996;157:5543-5554.
2. Townsend ARM, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986;44:959-968.
3. Kalish RA, Leong JM, Steere AC. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect Immun 1995;63:2228-22325.
4. Sears JE, et al. Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease. J Immunol 1991;147:1995-2000.
5. Schild H, Rotzschke O, Kalbacher H, Rammensee HG. Limit of T cell tolerance to self proteins by peptide presentation. Science 1990;247:1587-1589.
6. Sercarz E, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993;11:729-766.
7. Moudgil KD, Sercarz EE. Dominant determinants in hen eggwhite lysozyme correspond to the cryptic determinants within its self-homolog, mouse lysozyme: implications in the shaping of the T cell repertoire and autoimmunity. J Exp Med 1993;178:2131-2138.
8. Mamula M. The inability to process a self peptide allows T cells to escape tolerance. J Exp Med 1993;177:567-571.
9. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-157.
10. Garza KM, Griggs ND, Tung KSK. Neonatal injection of an ovarian peptide induces autoimmune ovarian disease in female mice: requirement of endogenous neonatal ovaries. Immunity 1997;6:89-96.
11. Bockenstedt LK, Gee R, Mamula MJ. Self peptides in the initiation of lupus autoimmunity. J Immunol 1995;154:3516-3524.
12. Kaufman DL, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993;366:69-72.
13. McRae, BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of EAE in the SJL/J mouse. J Exp Med 1995;182:75-85.
14. Fatenejad S, Brooks W, Schwartz A, Craft J. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/MP-1pr/1pr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target. J Immunol 1994;152:5523-5527.
15. Tian J, Lehmann PV, Kaufman DL. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J Exp Med 1997;186:2039-2043.
16. Fatenejad S, Mamula MJ, Craft J. Role of intermolecular/intrastructural B and T cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc Natl Acad Sci USA 1993;90: 12010-12014.
17. Bloom DD, Davignon J, Cohen P, Eisenberg RA, Clarke SH. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. J Immunol 1993;150:1579-1590.
18. Stephenson RC, Clarke S. Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J Biol Chem 1989;264:6164-6170.
19. Najbauer J, Orpiszewski J, Aswad DW. Molecular aging of tubulin: accumulation of isoaspartyl sites in vitro and in vivo. Biochemistry 1996;35:5183-5190.
20. Aswad DW. Deamidation and isoaspartate formation in peptides and proteins. In: Aswad DW, ed. Deamidation and isoaspartate formation in peptides and proteins. Boca Raton (FL): CRC Press 1995. p. 31-46.
21. Roher AE, et al. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993;268:3072-3083.
22. Galletti P, Ingrosso D, Manna C, Clemente G, Zappia V. Protein damage and methylation-mediated repair in the erythrocyte. Biochem J 1995;306:313-325.
23. Tsai W, Clarke S. Amino acid polymorphisms of the human L-isoaspartyl/D-aspartyl methyltransferase involved in protein repair. Biochem Biophys Res Commun 1994;203:491-497.
24. Kim E, Lowensen JD, MacLaren DC, Clarke S, Young SG. Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc Natl Acad Sci USA 1997;94:6132-6137.
25. Cunningham MW Molecular mimicry: bacterial antigen mimicry. In: Bona CA, ed. The molecular pathology of autoimmunity. New York: Harvard Academic; 1993. p.245-256.
26. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80:695-705.
27. Roth R, Nakamura T, Mamula MJ. Costimulation and autoantigen specificity enable B cells to activate autoreactive T cells. J Immunol 1996;157:2924-2931.
28. Roth R, Mamula MJ. B lymphocytes as autoantigen presenting cells in the amplification of autoimmunity. Ann N Y Acad Sci 1997;815:88-104.
29. James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: SmB/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995;181:453-461.
30. Topfer F, Gordon T, McCluskey J. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La(SS-B) and Ro(SS-A). Proc Natl Acad Sci USA 1995;92:875-879.
31. Mamula MJ, Fatenejad S, Craft J. B Cells process and present lupus autoantigens that initiate autoimmune T cell responses. J Immunol 1994;152:1453-1461.
32. Pierce SK, et al. Antigen-presenting function of B lymphocytes. Immunol Rev 1988;106:149-181.
33. Lanzavecchia A. Receptor mediated antigen uptake and its effect on antigen presentation to class II restricted T lymphocytes. Annu Rev Immunol 1990;8:773-777.
34. Weiser P, Muller R, Braun U, Reth M. Endosomal targeting by the cytoplasmic tail of the membrane immunoglobulin. Science 1997;276:407-409.
35. Tarlinton D. Antigen presentation by memory B cells: the sting is in the tail. Science 1997;276:374-375.
36. Noelle R, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus dependent B cell activation. Immunol Today 1992;13:431-436.
37. Lenschow DJ, et al. Differential up regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J Immunol 1994;153:1990-1995.
38. Ho WH, Cooke MP, Goodnow CC, Davis M. Resting and anergic B cells are defective in CD 28 dependent co-stimulation of naive CD4 T cells. J Exp Med 1994;179:1539-1546.
39. Davidson HW Watts C. Epitope directed processing of specific antigen by B lymphocytes. J Cell Biol 1989;109:85-90.
40. Ozaki S, Berzofsky JA. Antibody conjugates mimic specific B cell presentation of antigen: relationship between T and B cell specificity. J Immunol 1987;138:4133-4140.
41. Watts C, Lanzavecchia A. Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 1993;178:1459-1463.
42. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996;184:2271-2278.
43. Serreze DV, et al. B lymphocytes are essential for the initiation of T cell mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J Exp Med 1996;184:2049-2053.
44. Shlomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 1994;180:1295-1306.
45. Chambers CA, Allison JP. Co-stimulation in T cell responses. Curr Opin Immunol 1997;9:396-404.
46. Tivol EA, Schweitzer AN, Sharpe AH. Costimulation and autoimmunity. Curr Opin Immunol 1996;8:822-830.
47. Racke MK, et al. Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyelitis. J Clin Invest 1995;96:2195-2203.
48. Kuchroo V, et al. B7-1 and B7-2 costimulatory molecules differentially activate the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-716.
49. Nakajima A, et al. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur J Immunol 1995;25:3060-3069.
50. Lane P, Haller C, McConnell F. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4Ig protects Vβ8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B. Eur J Immunol 1996;26:858-862.
51. Tivol EA, Bordello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995;3:541-547.
52. Waterhouse P, et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995;270:985-988.
53. Cross AH, et al. Long term inhibition of murine experimental autoimmune encephalomyelitis using CTLA4-Fc supports a key role for CD 28 costimulation. J Clin Invest 1995;95:2783-2789.
54. Perrin PJ, et al. Role of B7/CD28 CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J Immunol 1995;154:1481-1490.
55. Khoury SJ, et al. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol 1995;155:4521-4524.
56. Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus by CTLA4Ig. Science 1994;265:1225-1227.
57. Daikh DI, Finck BK, Linsley PS, Hollenbaugh D, Wofsy D. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol 1997;159:3104-3108.